Editorial Board

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search

Our editorial board is comprised of cancer experts, organized primarily by disease focus. Most disease types now have expert representation, but we are still looking for potential section or page editors. If you are interested, please feel free to contact us with any questions or inquiries, at [email protected].

Editor-in-Chief

PeterYang.jpg
Peter C. Yang, MD
Boston, MA

Social-twitter-icon.png Hem_Onc
Dr. Yang is board certified in Hematology and Medical Oncology; he practices at an academically affiliated institution in Massachusetts.

Deputy Editor

Warner, Jeremy MD 2022.jpg
Jeremy L. Warner, MD, MS, FAMIA, FASCO
Brown University
Providence, RI

LinkedIn
Dr. Warner is board certified in Hematology, Medical Oncology, and Clinical Informatics; he practices at the Lifespan Cancer Institute. He is an Associate Professor (appointment pending) of Medicine and Public Health at Brown University. He is the Director of the Brown/Lifespan Center for Cancer Bioinformatics and Data Science.

Associate Editors

Evidence-based Oncology
Bishalgyawali.jpg
Bishal Gyawali, MD, PhD
Queen’s University
Kingston, Canada

Social-twitter-icon.png oncology_bg
Dr. Gyawali is an Associate Professor in the Departments of Oncology and Public Health Sciences at Queen’s University, Kingston, Canada and an Ontario Institute for Clinical Research-Scientist II. He is an advocate of a "cancer groundshot", a term he coined to imply that investment should be made on proven high-value interventions in cancer care that are easy to implement globally and are affordable.
Cancer Registries
Mesnard M.jpeg
Mary Mesnard, BS, CTR
LinkedIn
Ms. Mesnard is a senior study director at Westat and was formerly with the State of Maryland's central cancer registry.
Pediatric Hematology/Oncology
Liang.jpg
Wayne H. Liang, MD, MS, FAMIA
Emory University
Atlanta, GA

Social-twitter-icon.png WayneLiangMD
LinkedIn
Dr. Liang is board certified in Pediatrics, Pediatric Hematology-Oncology, and Clinical Informatics; he practices at Children’s Healthcare of Atlanta. He is an Assistant Professor of Pediatrics at Emory University.
Radiation Oncology
Bitterman.jpeg
Danielle S. Bitterman, MD
Dana-Farber Cancer Institute
Boston, MA

LinkedIn
Dr. Bitterman is board certified in Radiation Oncology; she practices at Brigham and Women’s Hospital/Dana-Farber Cancer Institute. She is an Instructor of Radiation Oncology at Harvard Medical School.
Supportive Oncology
Lustberg.jpeg
Maryam B. Lustberg, MD, MPH
Yale University
New Haven, CT

LinkedIn
Dr. Lustberg is board certified in Medicine and Medical Oncology; she is the director of the Breast Center at Smilow Cancer Hospital and chief of Breast Medical Oncology at Yale Cancer Center. She is an Associate Professor of Internal Medicine (Medical Oncology) at Yale University. She is the co-chair of Symptom Intervention Committee for Alliance Clinical Trials, and the 2022 president of the Multinational Association of Cancer Supportive Care (MASCC)

Section Editors

Breast Oncology
Fernandes Hermina WEB160x200.jpg
H. Deepika Fernandes, MD, FACP
Tempe, AZ
Dr. Fernandes is board certified in Medical Oncology and Hematology; she practices at the HonorHealth Virginia G. Piper Cancer Care Network.
Dermatologic Oncology
Bethbuchbinder.jpg
Elizabeth Buchbinder, MD
Boston, MA

LinkedIn
Dr. Buchbinder is board certified in Medical Oncology; she is a senior physician at the Dana-Farber Cancer Institute. She is an Assistant Professor of Medicine at Harvard Medical School.
Endocrine Oncology
Unfilled If you are interested in this role, please contact us at [email protected].
Gastrointestinal Oncology, Intestinal
Unfilled If you are interested in this role, please contact us at [email protected].
Gastrointestinal Oncology, Extraintestinal
Eric Marks Headshot.jpg
Eric I. Marks, MD
Boston, MA
Dr. Marks is board certified in Medical Oncology; he practices at Boston Medical Center and is an Assistant Professor of Medicine at Boston University School of Medicine.
Genitourinary Oncology
Alikhaki.jpg
Ali Raza Khaki, MD
Palo Alto, CA
Dr. Khaki is board certified in Hematology and Medical Oncology; he practices at Stanford Health Care. He is a a Clinical Assistant Professor of Oncology at Stanford University School of Medicine.
Gynecologic Oncology
Brown-alaina.jpeg
Alaina J. Brown, MD, MPH
Nashville, TN
Dr. Brown is board certified in Gynecologic Oncology and Obstetrics and Gynecology; she practices at the Vanderbilt-Ingram Cancer Center. She is an Assistant Professor of Obstetrics and Gynecology at Vanderbilt University.
Head & Neck Cancer
Michaelgibson.jpg
Michael K. Gibson, MD, PhD, FACP
Nashville, TN

Social-twitter-icon.png mgibson21212
LinkedIn
Dr. Gibson is board certified in Medical Oncology; he practices at the Vanderbilt-Ingram Cancer Center, where he is the Director of Translational Research for Head and Neck Oncology. He is an Associate Professor of Medicine at Vanderbilt University.
Mesothelioma
Zauderer-majorie.jpeg
Marjorie G. Zauderer, MD
New York, NY

Social-twitter-icon.png MGZauderer
Dr. Zauderer is board certified in Medical Oncology; she is co-director of the mesothelioma program at Memorial Sloan Kettering Cancer Center.
Neuro-Oncology
SeemaNagpal.jpg
Seema Nagpal, MD
Palo Alto, CA
Dr. Nagpal is board certified in Neurology and UCNS certified in Neuro-Oncology; she practices at Stanford Health Care. She is a clinical associate professor at Stanford University
Sarcoma
Elizabethdavis2.jpg
Elizabeth J. Davis, MD
Nashville, TN

Social-twitter-icon.png ejdavis25
Dr. Davis is board certified in Medical Oncology; she practices at the Vanderbilt-Ingram Cancer Center and is the medical director of the Clinical Trials Office. She is an associate professor at Vanderbilt University.
Thoracic Oncology
Amit Kulkarni.jpg
Amit Kulkarni, MBBS
University of Minnesota
Minneapolis, MN

Social-twitter-icon.png AmitKulkarniMD
Dr. Kulkarni is board certified in Medical Oncology; he practices and is an Assistant Professor of Medicine, Division of Hematology, Oncology and Transplantation at the University of Minnesota.
Acute Leukemias
MartinSchoen.jpg
Martin W. Schoen, MD, MPH
Saint Louis University
St. Louis, MO
Dr. Schoen is board certified in Hematology and Medical Oncology; he practices at the Saint Louis Veterans Affairs Medical Center. He is an assistant professor at Saint Louis University.
Myeloproliferative Neoplasms and Myelodysplastic Syndromes
Sanjay mohan.png
Sanjay R. Mohan, MD, MSCI
Nashville, TN
Dr. Mohan is board certified in Hematology and Medical Oncology; he practices at the Vanderbilt-Ingram Cancer Center. He is an assistant professor at Vanderbilt University.
Aggressive Lymphomas & Lymphoproliferative disorders
TarsheenSethi.jpg
Tarsheen K. Sethi, MD, MSCI
Yale University
New Haven, CT

Social-twitter-icon.png tarsheen2
Dr. Sethi is board certified in Hematology and Medical Oncology; she practices at the Smilow Cancer Hospital at Yale New Haven. She is an assistant professor at Yale University.
Indolent Lymphomas
Sanjaisharma.jpg
Sanjai Sharma, MD
Visalia, CA
Dr. Sharma is board certified in Hematology and Medical Oncology; he practices at the Sequoia Regional Cancer Center.
Plasma Cell Dyscrasias
Headshot Cowan.jpg
Andrew J. Cowan, MD
Seattle, WA

Social-twitter-icon.png andrewcowanmd
LinkedIn
Dr. Cowan is board certified in Hematology and Medical Oncology; he is the Interim Clinical Director of the myeloma service at the Fred Hutch Cancer Center. He is an assistant professor at the University of Washington.
T-cell and NK-cell neoplasms
Bdholaria.jpg
Bhagirathbhai Dholaria, MBBS
Nashville, TN
Dr. Dholaria is board certified in Hematology and Medical Oncology; he practices at the Vanderbilt-Ingram Cancer Center. He is an assistant professor at Vanderbilt University.
Histiocyte Disorders
GauravGoyal.jpg
Gaurav Goyal, MBBS
UAB
Birmingham, AL

Social-twitter-icon.png GauravGoyalMD
Dr. Goyal is board certified in Hematology and Medical Oncology; he practices at the O'Neal Comprehensive Cancer Center at UAB Medicine. He is an assistant professor at UAB (The University of Alabama at Birmingham).
Pediatric Leukemia & Lymphoma
Noyd.png
David Noyd, MD, MPH
University of Oklahoma
Oklahoma City, OK
Dr. Noyd is board certified in Pediatrics and board eligible in Pediatric Hematology-Oncology; he practices at OU Health. He is an Assistant Professor of Pediatrics.
Pediatric Neuro-Oncology & Solid Tumors
Nwood.jpeg
Nikki M. Wood, DO
University of Missouri
Kansas City, MO

Social-twitter-icon.png WoodNikkiM
LinkedIn
Dr. Wood is board certified in Pediatrics and Pediatric Hematology-Oncology; she practices at Children's Mercy Kansas City. She is an Assistant Professor of Pediatrics.
Transplant
Hilal.jpg
Talal Hilal, MD
Mayo Clinic
Phoenix, AZ

Social-twitter-icon.png THilalMD
Dr. Hilal is board certified in Hematology and Medical Oncology; he practices at Mayo Clinic Arizona. He is an assistant professor at the Mayo Clinic.
Classical Hematology
Tillman Benjamin-2.jpg
Benjamin Tillman, MD
Vanderbilt University
Nashville, TN
Dr. Tillman is board certified in Hematology and Medical Oncology; he practices at the Vanderbilt-Ingram Cancer Center. He is an Assistant Professor of Medicine (Hematology/Oncology)
Clinical Pharmacology
Fitts.jpeg
Austin Fitts, PharmD
Vanderbilt University
Nashville, TN

LinkedIn
Dr. Fitts is a PGY2 Pharmacy Informatics Resident at Vanderbilt University Medical Center.
Living Systematic Reviews
Riaz.jpeg
Irbaz Bin Riaz, MD, PhD, MS
Mayo Clinic
Phoenix, AZ
Dr. Riaz is board certified in Internal Medicine and board eligible in Medical Oncology; he is currently a Mayo Clinic Scholar training in clinical informatics at the Harvard Medical School Clinical Informatics Program.

Page Editors

COI Disclosures

Please see our conflict of interest page for more details. Disclosures here are for COI within 12 months of the date of disclosure unless otherwise noted.

Name Research funding (to institution) Other (honoraria, travel support, significant ownership interests, etc.) Date of disclosure
Jon Arnason Nothing to disclose Nothing to disclose 2021-11-10
Danielle S. Bitterman Nothing to disclose Nothing to disclose 2022-11-10
Alaina J. Brown NIH Nothing to disclose 2022-08-03
Elizabeth Buchbinder NIH; Trial funding: Eli Lilly, Novartis, Partners therapeutics, Genentech, BVD Consulting/Advisory Board: Novartis, Apexigen, Shionogi, BMS, Instilbio, Nektar 2022-05-08
Andrew Cowan Abbvie, Nektar, Harpoon, Janssen, Adaptive, Sanofi, BMS, Celgene Consultancy: Abbvie, BMS, Secura Bio, EUSA, GSK 2022-04-26
Karine A. Darbinyan Nothing to disclose Nothing to disclose 2022-08-03
Elizabeth J. Davis Research funding: NIH/NCI; ECOG
Trial funding: Karyopharm, BMS, Incyte, Actuate, Bio Atla, Top Alliance Biosciences, Genentech
Consulting/Advisory Board: Deciphera 2021-11-10
Bhagirathbhai Dholaria Research funding: Janssen, Angiocrine, Pfizer, Poseida, MEI, Orcabio, Wugen, Allovir Consulting/Advisory Board: Jazz, Gamida Cell, MJH BioScience, Arivan Research, BEAM therapeutics, Janssen, Atheneum; Study steering committee: Gamida Cell 2022-08-04
H. Deepika Fernandes Nothing to disclose Nothing to disclose 2021-04-03
Teja Ganta Nothing to disclose Nothing to disclose 2022-08-05
Michael K. Gibson Nothing to disclose Nothing to disclose 2021-11-15
Gaurav Goyal Nothing to disclose Royalties from UpToDate and consulting fees from 2nd.MD 2022-08-02
Laura Graham Nothing to disclose Nothing to disclose 2022-08-04
Bishal Gyawali Nothing to disclose Consulting/Advisory Board: Vivio Health 2022-08-24
Talal Hilal Nothing to disclose Consulting/Advisory Board: Incyte
Editorship: Springer
2022-08-22
Ali R. Khaki Nothing to disclose Consulting/Advisory Board: Seagen/Astellas
Travel: BCAN; SABCS
Honoraria: Onclive CME
2021-11-11
Ashwin Kishtagari Nothing to disclose Consulting/Advisory Board: CTI BioPharma 2022-08-03
Mary L. Kwok Nothing to disclose Nothing to disclose 2022-04-21
Wayne H. Liang Nothing to disclose Consulting/Advisory Board: Westat 2021-11-10
Eric Marks Nothing to disclose Nothing to disclose 2022-04-25
Sanjay R. Mohan Trial funding: Incyte, Karyopharm, Novartis, Taiho Nothing to disclose 2022-04-22
Seema Nagpal Trial funding: Agios, PharmAbcine, Insightec, Berg, Inovio Consulting/Advisory Board: EnClear, SeaGen, Novocure Steering Committee, Nurix, Biocept Steering Committee; Guidelines: NCCN CNS committee, ARS-AUC CNS committee, ASTRO Brain metastases guideline committee 2022-04-22
Ryan Nguyen Nothing to disclose Nothing to disclose 2022-08-04
David Noyd Nothing to disclose Nothing to disclose 2022-08-31
Samuel R. Rubinstein Nothing to disclose Consulting/Advisory Board: Sanofi, Roche, Janssen, EUSA pharma 2022-08-03
Martin Schoen St. Louis Veterans Affairs Medical Center, Congressionally Directed Medical Research Program Consulting/Advisory Board: Doximity, Pfizer 2022-08-05
Sanjai Sharma Nothing to disclose Nothing to disclose 2022-08-04
Eric K. Singhi Nothing to disclose Nothing to disclose 2022-08-02
Benjamin F. Tillman Nothing to disclose Nothing to disclose 2021-10-13
Jeremy L. Warner AACR; NIH; Vanderbilt University Travel: AACR; ASCO
Ownership: HemOnc.org
Consulting/Advisory Board: Westat, MelaxTech, Roche, Flatiron Health; Editorship: ASCO
2022-05-08
Risa L. Wong Nothing to disclose Consulting/Advisory Board: Voluntis 2022-08-03
Nikki M. Wood Nothing to disclose Consulting/Advisory Board: Westat 2021-11-10
Peter C. Yang Nothing to disclose Ownership: HemOnc.org
Stock: Merck, Pfizer
2022-04-22
Marjorie Zauderer Memorial Sloan Kettering receives research funding from the Department of Defense, the National Institutes of Health, Precog, GlaxoSmithKline, Epizyme, Polaris, Sellas Life Sciences, Bristol Myers Squibb, Millenium/Takeda, Curis, and Atara for research conducted by Dr. Zauderer. In the last 3 years, Dr. Zauderer has received consulting fees from Curis, Ikena, Takeda, GlaxoSmithKline, Aldeyra Therapeutics, Novocure, and Atara and honoraria for CME content from PER, Medscape, Research to Practice, Medical Learning Institute and OncLive. Dr. Zauderer serves as Chair of the Board of Directors of the Mesothelioma Applied Research Foundation, uncompensated. 2022-10-20